SCHEMBL30278668

SCHEMBL30278668

CC(C)N1CCN(c2ccc([N+](=O)[O-])cc2F)CC1

nearest known ligand 0.66

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 6/20 0.66
LMNA P02545 5/20 0.66
KMT2A Q03164 2/20 0.64
MAPT P10636 3/20 0.59
THRB P10828 1/20 0.59
POLB P06746 2/20 0.53
DPP4 P27487 1/20 0.50
SLC6A5 Q9Y345 6/20 0.49
SLC6A9 P48067 5/20 0.49
KDM4E B2RXH2 1/20 0.49
TDP1 Q9NUW8 1/20 0.49
MEN1 O00255 1/20 0.48
MAPK1 P28482 1/20 0.48
SMN1; SMN2 Q16637 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13419533 1.00 ALDH1A1 (0.66) ALDH1A1LMNAKMT2AMAPTTHRB
SCHEMBL14464189 0.88 ALDH1A1 (0.79) ALDH1A1LMNAKMT2AMAPTTHRB
SCHEMBL28483262 0.88 ALDH1A1 (0.54) ALDH1A1LMNAKMT2AMAPTTHRB
SCHEMBL993621 0.84 ALDH1A1 (0.68) ALDH1A1LMNAKMT2AMAPTKDM4E
SCHEMBL32688941 0.84 KMT2A (0.53) ALDH1A1LMNAKMT2AMAPTTHRB
SCHEMBL1813107 0.84 KMT2A (0.53) ALDH1A1LMNAKMT2AMAPTTHRB
SCHEMBL854050 0.84 ALDH1A1 (0.71) ALDH1A1LMNAKMT2AMAPTTHRB
SCHEMBL30198175 0.84 ALDH1A1 (0.71) ALDH1A1LMNAKMT2AMAPTTHRB
SCHEMBL24267451 0.83 ALDH1A1 (0.53) ALDH1A1LMNAKMT2AMAPTTHRB
SCHEMBL1127006 0.83 ALDH1A1 (0.62) ALDH1A1LMNAKMT2AMAPTTHRB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-116003408-A Heterocyclic compound, and preparation method and application thereof 绵阳市中心医院 2023-04-25 CN disclosed
CN-115867549-A 1H-pyrrolo [3,2-c ] pyridine and 1H-pyrrolo [2,3-c ] pyridine derivatives as TLR9 inhibitors for the treatment of fibrosis 百时美施贵宝公司 2023-03-28 CN disclosed